Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-20 14:00 |
Communiqué de presse : Sanofi et Biovac pionniers de la production de vaccins c…
|
French | 134.9 KB | ||
| 2024-06-20 14:00 |
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabili…
|
English | 118.3 KB | ||
| 2024-06-12 20:19 |
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2…
|
French | 123.1 KB | ||
| 2024-06-12 20:19 |
Sanofi: Information concerning the total number of voting rights and shares – M…
|
English | 145.4 KB | ||
| 2024-06-11 19:54 |
6-K
|
English | 85.3 KB | ||
| 2024-06-03 22:15 |
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progr…
|
English | 263.1 KB | ||
| 2024-06-03 22:15 |
Communiqué de presse : ASCO : Sarclisa, en association avec un protocole VRd, e…
|
French | 279.2 KB | ||
| 2024-05-31 22:30 |
SC 13G
|
English | 16.6 KB | ||
| 2024-05-31 12:00 |
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
|
English | 178.4 KB | ||
| 2024-05-31 12:00 |
Communiqué de presse : Sanofi lance son plan mondial 2024 d’actionnariat salarié
|
French | 180.8 KB | ||
| 2024-05-31 07:05 |
Press Release: Dupixent recommended for EU approval by the CHMP to treat patien…
|
English | 211.5 KB | ||
| 2024-05-31 07:05 |
Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE p…
|
French | 239.7 KB | ||
| 2024-05-31 07:00 |
Press Release: Update on FDA priority review of Dupixent for the treatment of C…
|
English | 199.8 KB | ||
| 2024-05-31 07:00 |
Communiqué de presse : Point d’actualité sur l’examen prioritaire de la FDA rel…
|
French | 223.1 KB | ||
| 2024-05-30 22:30 |
6-K
|
English | 23.6 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
